Health In Tech Reports Q1 Net Loss and Negative Adjusted EBITDA Despite Revenue Growth
HIT has more than doubled off its 52-week low of $0.555 on elevated volume (2.2× avg).
Summary
Health In Tech reported a net loss of $1.6 million and negative Adjusted EBITDA in Q1 2026, a significant decline from the prior year, despite a 9.4% revenue increase. Operating cash flow was negative, with liquidity supported by a recent $6.38 million PIPE financing.
Key Events · Earnings and Guidance · HIT
-
Shift to Net Loss and Negative Adjusted EBITDA
The company reported a net loss of $1.6 million for Q1 2026, a significant decline from a net income of $0.5 million in Q1 2025. Adjusted EBITDA also turned negative, reaching $(1.3) million compared to $1.2 million in the prior year period.
-
Increased Operating Cash Burn
Net cash used in operating activities was $3.3 million for Q1 2026, a substantial increase from $0.5 million provided by operating activities in Q1 2025, indicating a significant increase in cash outflow from core operations.
-
Revenue Growth Driven by New Service Model
Total revenues increased by 9.4% to $8.8 million in Q1 2026, primarily driven by the launch of new self-funded plan administration services, which also contributed to higher costs.
-
PIPE Financing Provides Liquidity
The company received $6.38 million in net proceeds from a Private Investment in Public Equity (PIPE) financing completed on March 27, 2026, issuing 5.6 million Class A shares at $1.25 per share. This financing was critical for bolstering cash reserves amidst operational losses.
Analysis · HIT · Finance
Health In Tech's first-quarter results show a significant deterioration in profitability, shifting from a net income of $0.5 million in Q1 2025 to a net loss of $1.6 million in Q1 2026. Adjusted EBITDA also turned negative, indicating operational challenges despite a 9.4% increase in total revenues. The company experienced substantial cash burn from operating activities, using $3.3 million, which was partially offset by $6.38 million in net proceeds from a PIPE financing completed in March 2026. This financing is crucial for liquidity given the operational cash outflow. The increase in costs is attributed to the launch of new self-funded plan administration services and higher sales distribution fees.
At the time of this filing, HIT was trading at $1.23 on NASDAQ in the Finance sector, with a market capitalization of approximately $70.2M. The 52-week trading range was $0.56 to $4.02. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.